[Nephrotoxicity of antibiotics].
D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000935:Antifungal Agents / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects; D002701:Chloramphenicol / Q000009:adverse effects; D004917:Erythromycin / Q000009:adverse effects; D005578:Fosfomycin / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D010406:Penicillins / Q000009:adverse effects; D010455:Peptides / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects; D013754:Tetracyclines / Q000009:adverse effects
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D000935:Antifungal Agents; D002511:Cephalosporins; D010406:Penicillins; D010455:Peptides; D013754:Tetracyclines; D005578:Fosfomycin; D004917:Erythromycin; D002701:Chloramphenicol; D012293:Rifampin
La nefrotossicità degli antibiotici